Karyopharm and Menarini Group Receive Positive CHMP Opinion fo...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
NEWTON, Mass. and FLORENCE, Italy, May 20, 2022 /PRNewswire-AsiaNet/ -- -- European Commission Decision Anticipated within Approximately 60 Days --Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, and the Menarini Group ("Menarini"), a private...
Authors: LATEST ASIANET NEWS RELEASES